Gopa Iyer
Cited by
Cited by
Genome sequencing identifies a basis for everolimus sensitivity
G Iyer, AJ Hanrahan, MI Milowsky, H Al-Ahmadie, SN Scott, ...
Science 338 (6104), 221-221, 2012
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
JS Damrauer, KA Hoadley, DD Chism, C Fan, CJ Tiganelli, SE Wobker, ...
Proceedings of the National Academy of Sciences 111 (8), 3110-3115, 2014
Convergent loss of PTEN leads to clinical resistance to a PI (3) Kα inhibitor
D Juric, P Castel, M Griffith, OL Griffith, HH Won, H Ellis, SH Ebbesen, ...
Nature 518 (7538), 240-244, 2015
Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma
EM Van Allen, KW Mouw, P Kim, G Iyer, N Wagle, H Al-Ahmadie, C Zhu, ...
Cancer discovery 4 (10), 1140-1153, 2014
Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer
G Iyer, H Al-Ahmadie, N Schultz, AJ Hanrahan, I Ostrovnaya, AV Balar, ...
Journal of Clinical Oncology 31 (25), 3133, 2013
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: an exploratory multi-omic analysis
A Snyder, T Nathanson, SA Funt, A Ahuja, J Buros Novik, MD Hellmann, ...
PLoS medicine 14 (5), e1002309, 2017
BRAF mutation is associated with early stage disease and improved outcome in patients with low‐grade serous ovarian cancer
RN Grisham, G Iyer, K Garg, D DeLair, DM Hyman, Q Zhou, A Iasonos, ...
Cancer 119 (3), 548-554, 2013
Phase II study of everolimus in metastatic urothelial cancer
MI Milowsky, G Iyer, AM Regazzi, H Al-Ahmadie, SR Gerst, I Ostrovnaya, ...
BJU international 112 (4), 462, 2013
Genomic characterization of upper tract urothelial carcinoma
JP Sfakianos, EK Cha, G Iyer, SN Scott, EC Zabor, RH Shah, Q Ren, ...
European urology 68 (6), 970-977, 2015
DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma
MY Teo, RM Bambury, EC Zabor, E Jordan, H Al-Ahmadie, ME Boyd, ...
Clinical cancer research 23 (14), 3610-3618, 2017
Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder
PH Kim, EK Cha, JP Sfakianos, G Iyer, EC Zabor, SN Scott, I Ostrovnaya, ...
European urology 67 (2), 198-201, 2015
Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy
H Al-Ahmadie, G Iyer, M Hohl, S Asthana, A Inagaki, N Schultz, ...
Cancer discovery 4 (9), 1014-1021, 2014
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer
HA Al-Ahmadie, G Iyer, BH Lee, SN Scott, R Mehra, A Bagrodia, ...
Nature genetics 48 (4), 356-358, 2016
Genetic determinants of cisplatin resistance in patients with advanced germ cell tumors
A Bagrodia, BH Lee, W Lee, EK Cha, JP Sfakianos, G Iyer, EJ Pietzak, ...
Journal of Clinical Oncology 34 (33), 4000, 2016
Oncogenic activation of Pak1-dependent pathway of macropinocytosis determines BCG entry into bladder cancer cells
G Redelman-Sidi, G Iyer, DB Solit, MS Glickman
Cancer research 73 (3), 1156-1167, 2013
Extreme outlier analysis identifies occult mitogen-activated protein kinase pathway mutations in patients with low-grade serous ovarian cancer
RN Grisham, BE Sylvester, H Won, G McDermott, D DeLair, R Ramirez, ...
Journal of Clinical Oncology 33 (34), 4099, 2015
Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors
DR Feldman, G Iyer, L Van Alstine, S Patil, H Al-Ahmadie, VE Reuter, ...
Clinical Cancer Research 20 (14), 3712-3720, 2014
Somatic mutation of fibroblast growth factor receptor‐3 (FGFR3) defines a distinct morphological subtype of high‐grade urothelial carcinoma
HA Al‐Ahmadie, G Iyer, M Janakiraman, O Lin, A Heguy, SK Tickoo, ...
The Journal of pathology 224 (2), 270-279, 2011
Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer
RN Grisham, G Iyer, E Sala, Q Zhou, A Iasonos, D DeLair, DM Hyman, ...
International Journal of Gynecologic Cancer 24 (6), 2014
Fibroblast growth factor receptor-3 in urothelial tumorigenesis
G Iyer, MI Milowsky
Urologic Oncology: Seminars and Original Investigations 31 (3), 303-311, 2013
The system can't perform the operation now. Try again later.
Articles 1–20